| 000 | 01012 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514125724.0 | ||
| 264 | 0 | _c19981101 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0096-0284 | ||
| 024 | 7 |
_a10.1177/009127006200200605 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKURLAND, A A | |
| 245 | 0 | 0 |
_aClinical trial of haloanisone (R-2028) with hospitalized psychiatric patients. _h[electronic resource] |
| 260 |
_bThe Journal of new drugs _c |
||
| 300 |
_a352-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aButyrates |
| 650 | 0 | 4 | _aButyrophenones |
| 650 | 0 | 4 | _aFluorides |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypnotics and Sedatives |
| 650 | 0 | 4 | _aKetones |
| 650 | 0 | 4 | _aPatients |
| 650 | 0 | 4 | _aPiperazines |
| 650 | 0 | 4 | _aSchizophrenia |
| 700 | 1 | _aMcCUSKER, K | |
| 700 | 1 | _aMICHAUX, W W | |
| 773 | 0 |
_tThe Journal of new drugs _gvol. 2 _gp. 352-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/009127006200200605 _zAvailable from publisher's website |
| 999 |
_c13693445 _d13693445 |
||